Monopar Therapeutics (MNPR) Financials

$117.56

$-0.99 (-0.84%)

As on 04-Sep-2026 18:47EDT

Market cap

$789 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

6.1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Operating Expenses	22.12	16.70	16.16	8.83	10.54	9.13
Operating Profit (EBIT)	-22.12	-16.70	-16.16	-8.83	-10.54	-9.13
Other Income	--	--	--	--	--	--
Profit before Tax	-17.84	-13.72	-15.59	-8.40	-10.52	-9.10
Provision for Tax	--	--	--	-0.01	-0.02	-0.02
Profit after Tax (Net Income)	-17.84	-13.72	-15.59	-8.40	-10.49	-9.08
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	--	-9.10

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	130.85	137.83	55.04	5.59	10.09	18.94
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.11	0.15	--	--	0.01	1.58
Current Liabilities	4.02	2.74	5.25	1.76	3.13	1.58
Total Liabilities	138.99	140.72	60.29	7.35	13.23	20.52

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	0.22	0.25	60,230.78	0.01	0.06	--
Current Assets	134.76	140.46	60.29	7.33	13.17	20.52
Total Assets	138.99	140.72	60.29	7.35	13.23	20.52
Total Debt*	0.11	0.15	--	--	0.01	--
Net Current Assets	130.75	137.73	55.04	5.58	10.04	18.94

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-12.20	-6.40	-7.86	-7.23	-7.32
Cash Flow from Investing Activities	--	-63.45	-14.34	4.93	-4.92	--
Cash from Financing Activities	--	91.57	59.29	2.03	0.03	10.88
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-2.34	-2.05	-1.36	-0.56	-0.81	-0.72
Cash EPS ($)	--	-2.05	-1.36	-0.56	-0.81	-0.72
Adjusted Book Value ($)	--	20.60	4.79	0.37	0.78	1.51
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.82	-0.56	-0.53	-0.56	-0.58
Free Cash Flow per Share ($)	--	-1.82	-0.56	-0.53	-0.56	-0.58

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-14.21	-51.42	-107.13	-72.28	-52.43
ROE (%)	-13.28	-14.22	-51.42	-107.19	-72.30	-52.43
ROA (%)	-18.35	-13.65	-46.09	-81.69	-62.19	-48.56
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	-1.00
EBIT Growth (%)	--	--	-277.86	20.26	-15.44	30.54
Net Profit Growth (%)	-3.10	11.99	-85.50	19.94	-15.59	-44.01
EPS Growth (%)	-30.51	-0.51	-1.41	0.30	-0.12	-0.27
Book Value Growth (%)	105.35	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-31.86	-16.21	-0.60	-2.92	-4.45
Price / Book Value	6.08	3.17	4.59	0.91	3.04	2.13
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-2.42	-21.63	-12.35	0.26	-1.67	-2.21
Close Price ($)	92.59	65.30	22.00	1.70	11.85	16.05
High Price ($)	105.00	105.00	38.50	19.10	24.40	85.05
Low Price ($)	29.18	21.00	1.55	1.37	6.96	15.10
Market Cap ($ Cr)	789.08	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.00	--	--	0.00	--
Short term debt to equity ratio	--	--	--	--	0.00	--
Current Ratio	33.56	51.35	11.47	4.17	4.21	12.98
Quick Ratio	33.56	--	--	--	--	--
Interest Coverage	--	--	--	--	-496.11	-379.92

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.